CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
271-285 of 1225

Calming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
CME/CECalming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis

Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents
CME/CEAdvances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents

NPS Psychosis: Circuits, Treatment, and New Hope
MinuteCE®NPS Psychosis: Circuits, Treatment, and New Hope

Closing the Loop: Structured Follow-Up and Patient Communication
MinuteCE®Closing the Loop: Structured Follow-Up and Patient Communication

NPS Agitation: Evidence and Emerging Mechanisms of Management
MinuteCE®NPS Agitation: Evidence and Emerging Mechanisms of Management
- advertisement

Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS
MinuteCE®Neuroinflammation to Network Instability: Translating FAAH/MAGL Biology to NPS

Moving Beyond Lid Hygiene: Evidence-Based Treatment Strategies
MinuteCE®Moving Beyond Lid Hygiene: Evidence-Based Treatment Strategies

Unseen Impact of NPS in AD: Domains and Burden
MinuteCE®Unseen Impact of NPS in AD: Domains and Burden

Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
MinuteCE®Return and Revisit: A 38-Year-Old Patient Returns for Follow-up After Lotilaner Treatment
- advertisement

The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
MinuteCE®The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment

Amyloid-β Therapies in Practice: Not All Are Created Equal
MinuteCE®Amyloid-β Therapies in Practice: Not All Are Created Equal


































